Skip to content
ppharmaranks
Menu

Best Alkylating Drug for lung neoplasms

Top-rated pick: Gleostine — pharmaranks score 72/100, the highest of the 3 Alkylating Drug drugs used for lung neoplasms, ranked by our independent FDA recall-safety score. Compare them with all treatments for lung neoplasms or the full Alkylating Drug class. Not medical advice — always consult a professional.

Quick answer: Of the 3 alkylating drug drugs we rate for lung neoplasms, none are yet flagged as generics in our price data, and most are capsule. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for lung neoplasms; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated July 13, 2026·How we rate

How alkylating drug work

Alkylating chemotherapy drugs attach chemical groups to a cell's DNA, forming cross-links that lock the two DNA strands together. This damage stops the cell from copying its DNA and dividing, which triggers it to die; because they are not limited to one phase of the cell cycle, they can act on cells whether or not they are actively dividing.

Source: Cyclophosphamide — StatPearls, NCBI Bookshelf (NIH)

Top alkylating drug for lung neoplasms: 1. Gleostine · 2. Lomustine · 3. Matulane

Best-rated Alkylating Drug for lung neoplasms, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100View →
2Not yet ratedView →
3Not yet ratedView →

Full ranking · 3 drugs

Frequently asked

What is the best alkylating drug for lung neoplasms?
By our independent recall-safety rating — not an efficacy measure — gleostine ranks highest among Alkylating Drug drugs used for lung neoplasms. Always consult a professional.
Which alkylating drug drugs treat lung neoplasms?
pharmaranks lists 3 Alkylating Drug products used for lung neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.